Biocomposites Ltd
{{</nowiki>Db-g7}}
| Headquarters | Keele, United Kingdom |
|---|---|
| Products | Stimulan geneX Bilok Biosteon Allogran-R Fortoss |
Staff | 83 |
| Website | https://www.biocomposites.com |
Biocomposites Ltd.[1] is a privately held medical device company that develops, manufactures, and markets devices to regenerate and repair bone and soft tissue. Biocomposites created the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue[2],[3] and the first synthetic bone graft with a negatively charged surface chemistry to accelerate bone healing in trauma.[4]
Biocomposites is currently the only supplier providing calcium sulfate antibiotic carriers to the UK’s NHS[5], [6]
The company reported £27.1 Million in annual revenue globally in 2018.[7] Biocomposites is a subsidiary of parent company Matrix Topco Limited.
History
Biocomposites Ltd was incorporated in 1997 following the management buyout of a ceramics company in Staffordshire, UK.[8]
In 1998, Biocomposites launched the first calcium composite device in sports injuries (reconstruction of cruciate ligaments) to receive both the CE mark and clearance from the FDA[9], and the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue.[10] Local anti-biotic carriers afford greater success rates by targeting the residual organisms present after debridement making them the standard treatment for chronic osteomyelitis and infected fractures. [11]
In 1999, Biocomposites launched a Synthetic calcium sulfate/beta-tricalcium phosphate bone graft for periodontal defects and implantology. The new invention was held to lead to a significantly favourable clinical improvement in periodontal intrabony defects two years after the surgery. In the same year, Biocomposites also released similar devices such as a highly consistent, polycrystalline and porous calcium phosphate bone substitute for use in trauma and spine and an antimicrobial peptide hLF1-11 from calcium phosphate bone substitutes in order to help prevent antimicrobial resistance.
In 2000, Biocomposites expanded by incorporating Biocomposites Inc. in Wilmington, NC, USA.[12] The company then went on to launch a Synthetic calcium composite device used for interference screws in the reconstruction of cruciate ligaments and suture anchors for rotator cuff repairs.[13] The device used is an alternative to conventional metal implants and produces comparable union rates to metallic devices in the short term.[14]
In 2004, Biocomposites relocated to custom-built headquarters in Keele, Staffordshire, UK
In 2017, TA Associates announced that it had completed its investment in Biocomposites. Financial terms of the transaction were not disclosed.[15]
References
- ↑ www.bloomberg.com https://www.bloomberg.com/profile/company/1515795D:LN. Retrieved 2021-07-01. Unknown parameter
|url-status=ignored (help); Missing or empty|title=(help) - ↑ Knight, Helen (21 February 2020). "Policy for the management of patients undergoing podiatric surgery within the Alliance using Stimulan Rapid Cure® Device" (PDF). University Hospital of Leicester NHS Trust – via NHS Trust.
- ↑ Aiken, Sean S.; Cooper, John J.; Florance, Hannah; Robinson, Matthew T.; Michell, Stephen (2014-08-22). "Local Release of Antibiotics for Surgical Site Infection Management Using High-Purity Calcium Sulfate: An In Vitro Elution Study". Surgical Infections. 16 (1): 54–61. doi:10.1089/sur.2013.162. ISSN 1096-2964. PMC 4363816. PMID 25148101.
- ↑ "Biocomposites Gets Approval for geneX® Putty". BioSpace. Retrieved 2021-07-01.
- ↑ Collaborative Procurement Partnership LLP (CPP) (1 July 2021). "NHS Supply Chain: Orthopaedic, Trauma and Spine, and Ophthalmology" (PDF). Total Orthopaedic Solutions 2 Framework - A Detailed Guide for NHS Providers – via NHS Trust.
- ↑ "Biocomposites Signs New Supplier Deal With NHS For Bone Repair Devices". Medtech Insight. 1 July 2021. Unknown parameter
|url-status=ignored (help) - ↑ "Biocomposites". Craft.CO. Unknown parameter
|url-status=ignored (help) - ↑ "Why Biocomposites? | Biocomposites". International. Retrieved 2021-07-01.
- ↑ "Biocomposites Gets Approval for geneX® Putty". BioSpace. Retrieved 2021-07-01.
- ↑ "Business Engagement and Innovation". Manchester.ac.uk. Retrieved 1 July 2021. Unknown parameter
|url-status=ignored (help) - ↑ "Ceramic Biocomposites as Biodegradable Antibiotic Carriers in the Treatment of Bone Infections". J. Bone Joint Infect., 2, 38–51, 2017. 1 Jan 2017 – via copernicus.org.
- ↑ "Biocomposites Inc". https://www.dnb.com/. Retrieved 1 July 2021. Unknown parameter
|url-status=ignored (help); External link in|website=(help) - ↑ Hopgood, P.; Kumar, R.; Wood, P. L. R. (2006-08-01). "Ankle arthrodesis for failed total ankle replacement". The Journal of Bone and Joint Surgery. British Volume. 88-B (8): 1032–1038. doi:10.1302/0301-620X.88B8.17627. ISSN 0301-620X. PMID 16877602.
- ↑ Ya'ish, F.; Bailey, C. A.; Kelly, C. P.; Craigen, M. A. (2013-01-01). "Bioabsorbable fixation of scaphoid fractures and non-unions; analysis of early clinical outcomes". Hand Surgery. 18 (3): 343–349. doi:10.1142/S0218810413500378. ISSN 0218-8104. PMID 24156576.
- ↑ "News | TA". TA Associates. Retrieved 2021-07-01.
This article "Biocomposites Ltd" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Biocomposites Ltd. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
